The Aditya Birla Sun Life NIFTY Healthcare ETF, managed by Aditya Birla Sun Life Asset Management Company, aims to replicate the returns of the Nifty Healthcare TRI index, focusing on sector-specific investments.

Employing a tracking approach, the fund seeks to minimize tracking error, currently at 0.04%, ensuring returns closely mirror its benchmark, though performance may vary due to inherent tracking risks.

With a fund size of ₹36.0 Cr, the ETF predominantly invests in Pharmaceuticals & Biotechnology, comprising 76.7% of the portfolio, with key holdings like Sun Pharmaceutical Industries at 17.8%.

Performance metrics indicate a 1-year return of +5.7% and a robust 3-year CAGR of 22.1%, showcasing consistency in returns, albeit with a modest tracking error compared to the benchmark.

The expense ratio stands at a low 0.19%, reflecting efficient cost management relative to the fund's complexity, while Ms. Priya Sridhar, with nearly a year of experience, leads the fund management.